Q3 2017 Holdings
Filed 2017-11-14 | 121 holdings | $2.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $972.6M | 25,819,768 | 45.3% |
| BioMarin Pharmaceutical Inc.(BMRN) | COM | 09061G101 | $549.6M | 5,905,673 | 25.6% |
| BeiGene, Ltd.(ONC) | SPONSORED ADR | 07725L102 | $403.3M | 3,898,431 | 18.8% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $85.1M | 2,348,840 | 4.0% |
| BioCryst Pharmaceuticals, Inc.(BCRX) | COM | 09058V103 | $73.3M | 13,997,172 | 3.4% |
| Cerus Corporation(CERS) | COM | 157085101 | $26.6M | 9,745,209 | 1.2% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | COM | 14888U101 | $12.9M | 5,102,153 | 0.6% |
| Agios Pharmaceuticals, Inc.(AGIO) | COM | 00847X104 | $8.6M | 128,666 | 0.4% |
| Incyte Corporation(INCY) | COM | 45337C102 | $4.0M | 34,230,323 | 0.2% |
| Seattle Genetics, Inc. | COM | 812578102 | $2.5M | 45,725,556 | 0.1% |
| argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $2.3M | 100,000 | 0.1% |
| Cellectis S.A.(CLLS) | SPONSORED ADS | 15117K103 | $1.4M | 50,000 | 0.1% |
| Alexion Pharmaceuticals, Inc.(ALXN) | COM | 015351109 | $1.2M | 8,553,864 | 0.1% |
| Arbutus Biopharma Corporation(ABUS) | COM | 03879J100 | $1.1M | 180,582 | 0.1% |
| Adaptimmune Therapeutics plc(ADAPY) | SPONSORED ADR | 00653A107 | $819.0K | 100,000 | 0.0% |
| Genomic Health, Inc.(GHDX) | COM | 37244C101 | $442.2K | 13,780,480 | 0.0% |
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $233.8K | 5,509,560 | 0.0% |
| Aquinox Pharmaceuticals, Inc. | COM | 03842B101 | $155.2K | 10,934,154 | 0.0% |
| Advanced Accelerator Applications S.A. | SPONSORED ADS | 00790T100 | $151.7K | 2,243,262 | 0.0% |
| Spark Therapeutics, Inc. | COM | 84652J103 | $123.4K | 1,384,130 | 0.0% |
| Amarin Corporation plc | SPONSORED ADR NEW | 023111206 | $79.3K | 22,669,509 | 0.0% |
| AveXis, Inc. | COM | 05366U100 | $75.0K | 775,000 | 0.0% |
| Invitae Corporation(NVTA1EUR) | COM | 46185L103 | $68.3K | 7,288,300 | 0.0% |
| Array BioPharma Inc.(ARRYEUR) | COM | 04269X105 | $64.1K | 5,213,528 | 0.0% |
| Achaogen, Inc. | COM | 004449104 | $62.0K | 3,886,878 | 0.0% |
| Bellicum Pharmaceuticals, Inc. | COM | 079481107 | $58.1K | 5,032,313 | 0.0% |
| Exelixis, Inc.(EXEL) | COM | 30161Q104 | $50.4K | 2,082,012 | 0.0% |
| Heron Therapeutics, Inc.(HRTX) | COM | 427746102 | $45.0K | 2,787,992 | 0.0% |
| Novavax, Inc. | NOTE 3.75% 2/1/2023 | 670002AB0 | $39.5K | $88,500,000 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | COM | 64125C109 | $37.8K | 616,682 | 0.0% |
| bluebird bio, Inc. | COM | 09609G100 | $33.2K | 241,441 | 0.0% |
| Sangamo Therapeutics, Inc.(SGMO) | COM | 800677106 | $31.7K | 2,113,376 | 0.0% |
| Acorda Therapeutics, Inc. | NOTE 1.75% 6/15/2021 | 00484MAA4 | $31.6K | $35,083,000 | 0.0% |
| Abeona Therapeutics Inc.(ABEO1EUR) | COM | 00289Y107 | $28.7K | 1,684,364 | 0.0% |
| Halozyme Therapeutics, Inc.(HALO) | COM | 40637H109 | $27.5K | 1,581,424 | 0.0% |
| Mirati Therapeutics, Inc.(MRTXEUR) | COM | 60468T105 | $26.5K | 2,269,198 | 0.0% |
| Galapagos NV(GLPG) | SPONSORED ADR | 36315X101 | $26.4K | 259,894 | 0.0% |
| Intellia Therapeutics, Inc.(NTLA) | COM | 45826J105 | $26.4K | 1,062,120 | 0.0% |
| Sage Therapeutics, Inc.(SG7) | COM | 78667J108 | $25.3K | 405,485 | 0.0% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | COM | 23257D103 | $24.1K | 2,991,775 | 0.0% |
| Progenics Pharmaceuticals, Inc. | COM | 743187106 | $23.2K | 3,150,808 | 0.0% |
| Merus N.V. | COM | N5749R100 | $23.0K | 1,160,014 | 0.0% |
| Idera Pharmaceuticals, Inc. | COM NEW | 45168K306 | $23.0K | 10,306,757 | 0.0% |
| NeuroDerm Ltd. | ORD SHS | M74231107 | $22.2K | 571,667 | 0.0% |
| Insmed Incorporated(INSM) | COM PAR $.01 | 457669307 | $21.8K | 700,000 | 0.0% |
| ImmunoGen, Inc.(IMGNEUR) | COM | 45253H101 | $20.6K | 2,688,489 | 0.0% |
| Xencor, Inc.(XNCR) | COM | 98401F105 | $20.0K | 872,072 | 0.0% |
| Aimmune Therapeutics, Inc.(AIMT) | COM | 00900T107 | $16.7K | 673,908 | 0.0% |
| Ignyta, Inc. | COM | 451731103 | $16.0K | 1,299,199 | 0.0% |
| MyoKardia, Inc. | COM | 62857M105 | $15.2K | 355,264 | 0.0% |